The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Yonsa Mpred (abiraterone acetate + methylprednisolone)
Australian Public Assessment Report
Device/Product Name
Yonsa Mpred
Active ingredients
Abiraterone acetate and methylprednisolone
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-04869-1-4
Submission Type
New combination of active ingredients (new composite pack)
Decision
Approved